2020: Inveniam Group Public Fundraising Success

2020 was our best year for public funding yet – raising over €20 million for 9 SME clients, as well as other consortium members. Additionally, 86% of the projects submitted to the EIC Accelerator programme received a Seal of Excellence from the European Commission evaluators, recognising the high quality of the proposals. “We want to congratulate all…

Einav Zilber firm – Inveniam’s new partner

At Inveniam we are very pleased to announce our new collaboration with Einav Zilber – IP Law. Patents. Management., an Israeli boutique intellectual property firm that delivers practical solutions to complex matters, focusing on business objectives, cost, and timeline. Einav Zilber, founder of the firm, collaborates with the Inveniam team as our IP Transactions Advisor.…

Yoran Imaging has been granted with 800,000€ by EIC Accelerator

We are happy to announce that our colleagues from Yoran Imaging have been granted with 800,000€ by EIC Accelerator (ex SME Instrument Phase 2). Yoran Imaging was established to provide effective sealed products inspection that perfects the quality assurance process of manufacturing facilities. Yoran has developed the PAM2 System, Packaging Analytics Monitoring System, a disruptive quality control machine that analysis all the products in a batch via 3D thermal imaging and advanced real time algorithms to provide complete in-line monitoring of the sealing process. The grant investment will enable Yoran to finalize the development of the PAM2 system by improving the Artificial Intelligence and to protect the IP and generate the go to market business plan.

Inveniam Group has closed a collaboration agreement with BHV Partners

We are very pleased to announce our new collaboration agreement with BHV Partners, the first venture builder in the Healthcare sector in Spain and Southern Europe. BHV Partners, with headquarters in Barcelona and San Francisco, has closed its first investment round of €0.5M thanks to the participation of private investors from the entrepreneurship sector, sector…

Inveniam’s commitment to ESG

Inveniam intends to take up this challagence by offering a quality service for the efficient assessment, measurement and integration of ESG criteria in the analysis of investments, transforming financial information into financial-social information.

Cellular immunotherapy to cope with Covid-19

At Inveniam Group, we would like to congratulate Dr. Rafael Correa Rocha, head of the Immune-Regulation Laboratory of Gregorio Marañón Hospital, for participating in a European consortium that promotes research on cellular immunotherapies to cope with Covid-19. The consortium is coordinated by the Hospital Clínic de Barcelona – IDIBAPS with support of the company Cellnex Telecom.